Surprise! President Trump signed four executive orders (EO) last Friday afternoon. They cover:
- Pass-through of 340B discounts for insulin and EpiPens
- Rebate reform (!)
- Importation
- Most Favored Nation (MFN) pricing for drugs
The fourth order on MFN has not been publicly released, so I will reserve comment for now.
I see significant challenges in implementing these far-reaching orders. Below, you’ll find the text of the first three along with my commentary and links to Drug Channels articles that will help you make sense of them.
Read on and see if you agree with me.
Read more »
Source: Post feed
